BERYL DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2024 ,inter alia, to consider and approve 1. To take note of general disclosures of interest of Directors under section 184 (1) in form MBP-1 for the year ended 2024-2025 2. To consider and approve the appointment of Abhay Bhandari & Associates, Chartered Accountants as Internal Auditor of the Company for the Financial Year 2024-2025. 3. To consider and approve the appointment of Dipika Kataria, Practicing Company Secretary as Secretarial Auditor of the Company for the year 2024-2025 4. Authority to Mr. Sudhir Sethi as signing authority to apply and sign all the tender related documents on behalf of the Company for the year 2024-2025